UPC - Universe Pharmaceuticals INC

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/09/2022
30/09/2021
30/09/2020
30/09/2019
Cash flows from operating activities
Net income
-8,737
-8,737
11,320
7,558
7,551
Depreciation & amortisation
533.949
533.949
446.878
410.079
418.431
Deferred income taxes
-605.278
-605.278
-668.341
-9.886
-39.625
Change in working capital
6,589
6,589
-12,686
-1,866
5,161
Accounts receivable
-1,549
-1,549
-3,867
-4,108
665.485
Inventory
16.586
16.586
-451.634
888.607
5,586
Accounts payable
-1,897
-1,897
2,457
639.427
-924.444
Other working capital
-1,406
-1,406
-15,587
6,063
13,117
Net cash provided by operating activities
-1,312
-1,312
-2,056
6,115
13,204
Cash flows from investing activities
Investments in property, plant and equipment
-93.703
-93.703
-13,531
-51.798
-86.324
Acquisitions, net
-3,815
-3,815
-
-
-
Purchases of investments
0
0
-15,331
-
-
Sales/maturities of investments
0
0
1,802
-
-
Net cash used for investing activities
-3,908
-3,908
-27,060
-51.798
-86.033
Cash flows from financing activities
Debt repayment
-4,273
-4,273
-3,676
-1,427
-3,055
Common stock issued
0
0
28,750
-
-
Dividends paid
0
0
0
0
-16,005
Other financing activities
-
-
-2,793
-441.064
1.143
Net cash used provided by (used for) financing activities
3,318
3,318
26,582
470.136
-16,004
Net change in cash
-2,366
-2,366
-1,980
6,881
-3,013
Cash at beginning of period
8,078
8,078
10,058
3,177
6,190
Cash at end of period
5,711
5,711
8,078
10,058
3,177
Free cash flow
Operating cash flow
-1,312
-1,312
-2,056
6,115
13,204
Capital expenditure
-93.703
-93.703
-13,531
-51.798
-86.324
Free cash flow
-1,406
-1,406
-15,587
6,063
13,117